Why Summit Therapeutics Stock Crushed the Market This Week
The company was a standout in the biotech field, rising by nearly 23% over the period.
Why Viking Therapeutics Stock Was Rocketing Higher This Week
Good news from the lab and subsequent price target lifts by analysts put some zip into the company's shares.
Why Lucid Stock Is Soaring Today
Lucid is receiving another major injection of capital.
Why Medical Properties Trust Stock Sank by More Than 5% Today
A pundit's new view of the company was surely affected by troubles with its top tenant.
Why Pure Storage Stock Was a Big Winner on Wednesday
A move up the index ranks and an analyst price target increase made for a price-boosting combination.
Is On Holding Stock Going to $40? 1 Wall Street Analyst Thinks So
The company is on a mission to double sales over the next three years.
Why Medical Properties Trust Plunged Today
The hospital real estate investment trust caught a downgrade to end the week.